Pelvic exenteration for advanced pelvic malignancies.
Our experience of 76 pelvic exenterations for advanced pelvic malignancies is presented, with emphasis on the results and complications. The overall operative mortality rate of 14% is acceptable, and a five-year survival rate of 20% has been achieved. The procedure has a definite role to play in the management of advanced but otherwise localized pelvic malignancies.
D005260:Female; D006801:Humans; D007890:Leiomyosarcoma / Q000601:surgery; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D010385:Pelvic Exenteration / Q000009:adverse effects / Q000401:mortality; D010386:Pelvic Neoplasms / Q000401:mortality / Q000601:surgery*